Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AETHLON MEDICAL INCAEMD · Entity 8580 | Director · Chief Executive Officer | February 10, 2022 | February 11, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AETHLON MEDICAL INC
Report date February 10, 2022 · Filed February 11, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.41 · Expires 2032-02-09 | Direct | 192,600 |
Reported balance
After 2022-02-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-02-10 · Grant · Acquired 192,600 · Balance 192,600 F1: 25% of the shares subject to the stock option shall vest and become exercisable on February 10, 2023, and the remaining shares shall vest and become exercisable in 36 equal monthly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: 25% of the shares subject to the stock option shall vest and become exercisable on February 10, 2023, and the remaining shares shall vest and become exercisable in 36 equal monthly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2022 Filed Feb 11, 2022 18:54 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantEmployee Stock Option (Right to Buy) · Derivative | 192,600 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001209191-22-008770 · doc4.xml · derivative · entry 1 FISHER CHARLES J JR · CIK 0001408469 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,600 Underlying: Common Stock · 192,600 shares Expires 2032-02-09 F1 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest and become exercisable on February 10, 2023, and the remaining shares shall vest and become exercisable in 36 equal monthly installments thereafter. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 18:23 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantEmployee Stock Option (Right to Buy) · Derivative | 266,888 | $0.00 Strike: $5.17 | $0.00 |
DisclosureSEC source: 0001209191-21-043935 · doc4.xml · derivative · entry 1 FISHER CHARLES J JR · CIK 0001408469 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,888 Underlying: Common Stock · 266,888 shares Expires 2031-06-27 F1 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest and become exercisable on June 28, 2022, and the remaining shares shall vest and become exercisable in 36 equal monthly installments thereafter. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:39 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 2,575 | $2.03 | $5,227.25 |
DisclosureSEC source: 0001209191-21-024739 · doc4.xml · nonDerivative · entry 1 FISHER CHARLES J JR · CIK 0001408469 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,569 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/3/20 Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 21:12 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 2,575 | $2.47 | $6,360.25 |
DisclosureSEC source: 0001209191-21-000257 · doc4.xml · nonDerivative · entry 1 FISHER CHARLES J JR · CIK 0001408469 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,144 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/3/20 Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 21:21 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantEmployee Stock Option (Right to Buy) · Derivative | 239,122 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001209191-20-056611 · doc4.xml · derivative · entry 1 FISHER CHARLES J JR · CIK 0001408469 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,122 Underlying: Common Stock · 239,122 shares Expires 2030-10-29 F1 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest and become exercisable on October 30, 2021, and the remaining shares shall vest and become exercisable in 36 equal monthly installments thereafter. Read SEC document |
| September 30, 2020 Filed Oct 1, 2020 17:53 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 2,389 | $1.35 | $3,225.15 |
DisclosureSEC source: 0001209191-20-052567 · doc4.xml · nonDerivative · entry 1 FISHER CHARLES J JR · CIK 0001408469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,719 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/3/20 Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 18:39 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 2,389 | $2.03 | $4,849.67 |
DisclosureSEC source: 0001209191-20-040113 · doc4.xml · nonDerivative · entry 1 FISHER CHARLES J JR · CIK 0001408469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,179 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/3/20 Read SEC document |
| April 03, 2020 Filed Apr 7, 2020 19:23 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantCommon Stock | 23,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-023742 · doc4.xml · nonDerivative · entry 1 FISHER CHARLES J JR · CIK 0001408469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,568 F1 · shares: The RSU's vests in four equal quarterly installments on 6/30/2020, 9/30/2020, 12/31/2020 and 3/31/2021. Read SEC document |
| April 03, 2020 Filed Sep 17, 2020 16:55 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantCommon Stock | 929 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-050819 · doc4.xml · nonDerivative · entry 1 FISHER CHARLES J JR · CIK 0001408469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,108 F1 · shares: The RSU was granted on 4/3/20, but was contingent on stockholder approval of the Issuer's 2020 Equity Incentive Plan at the Issuer's annual meeting of stockholders held on 9/15/20, and therefore for purposes of Section 16, the RSU was not "acquired" until such stockholder approval was obtained. The RSU's vest in two equal installments on 12/31/2020 and 3/31/2021. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 20:18 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 244 | $1.52 | $370.88 |
DisclosureSEC source: 0001209191-20-022545 · doc4.xml · nonDerivative · entry 1 FISHER CHARLES J JR · CIK 0001408469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,675 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/19 Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 00:04 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 246 | $0.84 | $207.60 |
DisclosureSEC source: 0001209191-20-000447 · doc4.xml · nonDerivative · entry 1 FISHER CHARLES J JR · CIK 0001408469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,919 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/19 F2 · balance_after: The end of period holdings reflect a 1-15 reverse stock split effected by the Issuer on October 14, 2019. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:49 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 3,684 | $0.24 | $865.74 |
DisclosureSEC source: 0001209191-19-051873 · doc4.xml · nonDerivative · entry 1 FISHER CHARLES J JR · CIK 0001408469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,469 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/19 Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 21:15 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 3,684 | $0.37 | $1,363.08 |
DisclosureSEC source: 0001209191-19-040452 · doc4.xml · nonDerivative · entry 1 FISHER CHARLES J JR · CIK 0001408469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,153 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/19 F2 · balance_after: Includes RSU's that were originally reported in Table II of the Reporting Person's Form 4 filed 4/3/19. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 19:16 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantRestricted Stock Units (RSU) · Derivative | 36,842 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023046 · doc4.xml · derivative · entry 1 FISHER CHARLES J JR · CIK 0001408469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,842 Underlying: Common Stock · 36,842 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. F2 · derivative.exercise_date: The RSU's vests in four equal quarterly installments on 6/30/19, 9/30/19, 12/31/19 and 3/31/20. F2 · derivative.expiration_date: The RSU's vests in four equal quarterly installments on 6/30/19, 9/30/19, 12/31/19 and 3/31/20. Read SEC document |
| March 31, 2019 Filed May 15, 2019 16:18 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 3,573 | $0.95 | $3,394.35 |
DisclosureSEC source: 0001209191-19-029882 · doc5.xml · nonDerivative · entry 3 FISHER CHARLES J JR · CIK 0001408469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,995 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU granted 6/14/18 Read SEC document |
| December 31, 2018 Filed May 15, 2019 16:18 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 3,573 | $1.30 | $4,644.90 |
DisclosureSEC source: 0001209191-19-029882 · doc5.xml · nonDerivative · entry 2 FISHER CHARLES J JR · CIK 0001408469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,568 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU granted 6/14/18 Read SEC document |
| September 30, 2018 Filed May 15, 2019 16:18 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 3,573 | $1.18 | $4,216.14 |
DisclosureSEC source: 0001209191-19-029882 · doc5.xml · nonDerivative · entry 1 FISHER CHARLES J JR · CIK 0001408469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,141 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU granted 6/14/18 Read SEC document |
| June 19, 2018 Filed Aug 1, 2018 01:14 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantRestricted Stock Units · Derivative | 26,799 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-18-002080 · ownership.xml · derivative · entry 1 FISHER CHARLES J JR · CIK 0001408469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,990 Underlying: Common Stock · 26,799 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: 26,595 restricted stock units vested on 12/31/2017 and 26,596 restricted stock units vested on 3/31/2018. 26,799 restricted stock units to vest ratably on 9/30/18, 12/31/18 and 3/31/19. F2 · derivative.expiration_date: 26,595 restricted stock units vested on 12/31/2017 and 26,596 restricted stock units vested on 3/31/2018. 26,799 restricted stock units to vest ratably on 9/30/18, 12/31/18 and 3/31/19. Read SEC document |
| June 14, 2018 Filed May 15, 2019 16:15 UTC Amendment | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantCommon Stock | 26,799 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-029881 · doc4a.xml · nonDerivative · entry 3 FISHER CHARLES J JR · CIK 0001408469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,714 F1 · balance_after: Includes RSU's that were originally reported in Table II of the Reporting Person's prior Form 4 filings. Read SEC document |
| March 31, 2018 Filed May 15, 2019 16:15 UTC Amendment | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 10,638 | $1.19 | $12,659.22 |
DisclosureSEC source: 0001209191-19-029881 · doc4a.xml · nonDerivative · entry 2 FISHER CHARLES J JR · CIK 0001408469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,915 F1 · balance_after: Includes RSU's that were originally reported in Table II of the Reporting Person's prior Form 4 filings. Read SEC document |
| December 31, 2017 Filed May 15, 2019 16:15 UTC Amendment | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 10,638 | $1.14 | $12,127.32 |
DisclosureSEC source: 0001209191-19-029881 · doc4a.xml · nonDerivative · entry 1 FISHER CHARLES J JR · CIK 0001408469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,553 F1 · balance_after: Includes RSU's that were originally reported in Table II of the Reporting Person's prior Form 4 filings. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.